|1.||Kropec, A: 1 article (04/2015)|
|2.||Huebner, J: 1 article (04/2015)|
|3.||Laverde, D: 1 article (04/2015)|
|4.||Wobser, D: 1 article (04/2015)|
|5.||Rossmann, F S: 1 article (04/2015)|
|6.||Saaverda, F R: 1 article (04/2015)|
|7.||Salihoglu, Ozgül: 1 article (11/2013)|
|8.||Koç, Melike Ozberk: 1 article (11/2013)|
|9.||Durmus, Eda: 1 article (11/2013)|
|10.||Hatipoglu, Sami: 1 article (11/2013)|
01/01/1999 - "CLINICAL PHASE: Phase III. Placebo-controlled investigation of the clinical efficacy of Pentaglobin (Biotest, Germany) as an added treatment in patients with mediastinitis. "
01/01/1999 - "Adjuvant treatment of mediastinitis with immunoglobins (Pentaglobin) after cardiac surgery (ATMI): study protocol."
01/01/1999 - "Sternal wound infections and mediastinitis after cardiac surgery are to be investigated in the ATMI study with Pentaglobin. "
01/01/1999 - "Consensus-assisted protocol development and discussion forum of a study protocol on adjuvant treatment of mediastinitis with immunoglobulins (pentaglobulin) after cardiac surgery (ATMI)."
01/01/1999 - "Microbiology and antibiotic treatment--discussion forum on a study protocol on adjuvant treatment of mediastinitis with immunoglobulins (Pentaglobin) after cardiac surgery (ATMI)."
11/01/2013 - "Pentaglobin treatment of nosocomial sepsis could be used as an adjunct therapy without any adverse short-term reactions, even in very low birthweight pre-term infants."
11/01/2013 - "To evaluate the effect of pentaglobin treatment on clinical and laboratory parametres and the major morbidities in very low birthweight neonates with nosocomial sepsis before and after pentaglobin treatment. "
11/01/2013 - "Pentaglobin as an adjunct therapy in very low birthweight neonates with nosocomial sepsis."
05/01/2013 - "Anesthetized and mechanically ventilated pigs, mean weight 14.9 kg, were allocated into two groups of 8 animals, receiving either Pentaglobin or saline, before sepsis was induced by intravenous Escherichia coli infusion. "
10/01/2001 - "[The effect of pentaglobin therapy on prognosis in patients with severe sepsis]."
06/01/1992 - "Pentaglobin has been postulated to have anti-endotoxin properties and one of the aims of the study was to measure endotoxin levels in these patients together with the clinical sequelae of infection. "
10/29/2004 - "Pentaglobin has a positive influence on the course of post-surgery intra-abdominal infection."
10/29/2004 - "Sixty-four patients with abdominal infection were treated with Pentaglobin or Albumin. "
06/01/1992 - "Those patients who received Pentaglobin were significantly protected from dying from infection in the first 100 days after the transplant, although it was not actually possible to document bacterial infections as the cause of death in the control patients. "
10/29/2004 - "IgM-enriched immunoglobulin (pentaglobin) positively influences the course of post-surgical intra-abdominal infections."
|4.||Septic Shock (Toxic Shock Syndrome)
08/01/2002 - "Septic shock incidence (38% versus 57%) and 28-day mortality rate (23.8% versus 33.3%) were found to be similar between the Pentaglobin and control groups. "
09/01/2005 - "Pentaglobin is a promising adjuvant therapy both clinically and economically for treatment of adults with severe sepsis and septic shock."
09/01/2005 - "To measure the cost-effectiveness of a specific polyclonal intravenous immune globulin preparation (Pentaglobin) in adult patients treated for severe sepsis and septic shock. "
08/01/2002 - "Present data could not demonstrate any beneficial effects of polyclonal immunoglobulin preparation Pentaglobin on organ morbidity, septic shock incidence and mortality rate in patients with severe sepsis."
09/01/2005 - "Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock."
|3.||Immunoglobulin M (IgM)
|4.||Intravenous Immunoglobulins (IVIG)
|5.||Immunoglobulin G (IgG)
|6.||Immunoglobulin A (IgA)
|8.||Anti-Bacterial Agents (Antibiotics)
|10.||Interleukin-6 (Interleukin 6)
|2.||Stem Cell Transplantation
|4.||Intensive Care (Surgical Intensive Care)
|5.||Drug Therapy (Chemotherapy)